No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: What else can RVX treat that we don’t know about yet?

Totally agree.

We just have not seen market hype in epigenetics and we have and continue to see it in genetic editing.

This is just another reason that RVX and Zenith Epigenetics need to get on the Nasdaq.

 

bfw

Share
New Message
Please login to post a reply